JP2018528242A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528242A5
JP2018528242A5 JP2018515619A JP2018515619A JP2018528242A5 JP 2018528242 A5 JP2018528242 A5 JP 2018528242A5 JP 2018515619 A JP2018515619 A JP 2018515619A JP 2018515619 A JP2018515619 A JP 2018515619A JP 2018528242 A5 JP2018528242 A5 JP 2018528242A5
Authority
JP
Japan
Prior art keywords
formulation
aprotic solvent
ionization
glucagon peptide
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018515619A
Other languages
English (en)
Japanese (ja)
Other versions
JP6835831B2 (ja
JP2018528242A (ja
Filing date
Publication date
Priority claimed from US15/136,650 external-priority patent/US9649364B2/en
Application filed filed Critical
Publication of JP2018528242A publication Critical patent/JP2018528242A/ja
Publication of JP2018528242A5 publication Critical patent/JP2018528242A5/ja
Application granted granted Critical
Publication of JP6835831B2 publication Critical patent/JP6835831B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018515619A 2015-09-25 2016-09-25 非プロトン性極性溶媒中の安定な治療用グルカゴン製剤を製造するための方法 Active JP6835831B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562233032P 2015-09-25 2015-09-25
US62/233,032 2015-09-25
US15/136,650 2016-04-22
US15/136,650 US9649364B2 (en) 2015-09-25 2016-04-22 Methods for producing stable therapeutic formulations in aprotic polar solvents
PCT/US2016/053628 WO2017053922A1 (en) 2015-09-25 2016-09-25 Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

Publications (3)

Publication Number Publication Date
JP2018528242A JP2018528242A (ja) 2018-09-27
JP2018528242A5 true JP2018528242A5 (cg-RX-API-DMAC7.html) 2019-09-12
JP6835831B2 JP6835831B2 (ja) 2021-02-24

Family

ID=57113760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018515619A Active JP6835831B2 (ja) 2015-09-25 2016-09-25 非プロトン性極性溶媒中の安定な治療用グルカゴン製剤を製造するための方法

Country Status (16)

Country Link
US (6) US9649364B2 (cg-RX-API-DMAC7.html)
EP (2) EP3352780B1 (cg-RX-API-DMAC7.html)
JP (1) JP6835831B2 (cg-RX-API-DMAC7.html)
KR (2) KR102769685B1 (cg-RX-API-DMAC7.html)
CN (2) CN108135980B (cg-RX-API-DMAC7.html)
AU (1) AU2016326749B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018005800A2 (cg-RX-API-DMAC7.html)
CA (2) CA3204984A1 (cg-RX-API-DMAC7.html)
DK (2) DK3352780T3 (cg-RX-API-DMAC7.html)
EA (1) EA201890704A1 (cg-RX-API-DMAC7.html)
ES (1) ES2970863T3 (cg-RX-API-DMAC7.html)
IL (1) IL258298B (cg-RX-API-DMAC7.html)
MX (1) MX2018003705A (cg-RX-API-DMAC7.html)
SA (1) SA518391187B1 (cg-RX-API-DMAC7.html)
WO (1) WO2017053922A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA201801912B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019173338A1 (en) * 2018-03-07 2019-09-12 Reform Biologics, Llc Excipient compounds for protein formulations
US10478498B2 (en) 2014-06-20 2019-11-19 Reform Biologics, Llc Excipient compounds for biopolymer formulations
US11357857B2 (en) 2014-06-20 2022-06-14 Comera Life Sciences, Inc. Excipient compounds for protein processing
US20160074515A1 (en) 2014-06-20 2016-03-17 Reform Biologics, Llc Viscosity-reducing excipient compounds for protein formulations
JP2020527396A (ja) 2017-07-14 2020-09-10 ゼリス ファーマシューティカルズ インコーポレイテッド 先天性高インスリン症を処置する方法
MX2020006658A (es) * 2017-12-22 2020-11-06 Xeris Pharmaceuticals Inc Tratamiento de hipoglucemia inducida por el ejercicio en la diabetes tipo 1 y tipo 2 en la que se usa insulina.
AU2019211352A1 (en) * 2018-01-23 2020-07-30 Joslin Diabetes Center, Inc. Treatment of post-bariatric hypoglycemia using mini-dose stable glucagon
US11576951B2 (en) 2019-05-31 2023-02-14 Xeris Pharmaceuticals, Inc. Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
CN112807281A (zh) * 2019-10-31 2021-05-18 南京海维医药科技有限公司 包含血管紧张素ii的稳定组合物及其制备方法、使用方法
AU2021297529A1 (en) * 2020-06-26 2022-09-22 Xeris Pharmaceuticals, Inc. Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
US12128089B2 (en) 2022-05-26 2024-10-29 Slayback Pharma Llc Stable liquid compositions of glucagon
CN120152698A (zh) 2022-10-19 2025-06-13 Xeris药物公司 使用非质子极性溶剂的缓释可注射制剂
EP4604922A1 (en) 2022-10-19 2025-08-27 Xeris Pharmaceuticals, Inc. Stable levothyroxine compositions in aprotic polar solvents
WO2025184608A1 (en) * 2024-02-28 2025-09-04 I2O Therapeutics, Inc. Compositions comprising pharmaceutically acceptable salts and other derivatives of an amylin analog and uses thereof
WO2025184589A1 (en) * 2024-02-28 2025-09-04 I2O Therapeutics, Inc. Compositions comprising pharmaceutically acceptable salts and other derivatives of glucagon-like peptide-1 receptor agonists and uses thereof

Family Cites Families (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016895A (en) 1958-08-01 1962-01-16 Pan American Lab Inc Injector for subcutaneous implantation of solids
US5260306A (en) 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB2119248A (en) 1982-04-28 1983-11-16 John Kenneth Mcmullen Insulin formulations and method of producing them
CH664005A5 (de) 1984-05-19 1988-01-29 Glatt Maschinen & Apparatebau Verfahren zum trocknen eines teilchenfoermigen gutes und einrichtung zur durchfuehrung des verfahrens.
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US4927571A (en) 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
US4848094A (en) 1988-04-29 1989-07-18 Union Carbide Corporation Droplet freezing method and apparatus
US5031336A (en) 1989-08-31 1991-07-16 Abbott Laboratories Lyophilization of bulk pharmaceuticals
US5092843A (en) 1990-04-12 1992-03-03 Survival Technology, Inc. Dispersion multichamber auto-injector
WO1991016882A1 (en) 1990-05-08 1991-11-14 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
ES2117642T3 (es) 1990-05-10 1998-08-16 Bechgaard Int Res Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
US5208998A (en) 1991-02-25 1993-05-11 Oyler Jr James R Liquid substances freeze-drying systems and methods
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
CA2130122A1 (fr) 1992-12-15 1994-06-16 Gabriel Meyer Dispositif pour la preparation d'une solution, d'une suspension ou d'une emulsion d'une substance medicinale
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5652216A (en) 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
KR970705979A (ko) 1994-09-29 1997-11-03 디 히스 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles)
US5932547A (en) 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
IN184589B (cg-RX-API-DMAC7.html) 1996-10-16 2000-09-09 Alza Corp
DK0949905T3 (da) 1996-12-20 2001-10-22 Alza Corp Injicertbart depotelpræparat og fremgangsmåde til fremstilling
WO1998029141A1 (en) 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
SI1285667T1 (sl) 1997-11-18 2006-10-31 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Farmacevtske raztopine za injiciranje paracetamola ali kombinacij paracetamola z drugimi aktivnimi substancami
FR2783433B1 (fr) 1998-09-18 2001-02-16 Delab Seringues pour l'administration de formulations pateuses ou semi-solides
SE9803662D0 (sv) 1998-10-26 1998-10-26 Pharmacia & Upjohn Ab Autoinjector
US6199297B1 (en) 1999-02-01 2001-03-13 Integrated Biosystems, Inc. Lyophilization apparatus and methods
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US6253463B1 (en) 1999-04-26 2001-07-03 Niro A/S Method of spray drying
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
US20030026844A1 (en) 2000-04-18 2003-02-06 Hee-Yong Lee Injectable sustained release pharmaceutical composition and processes for preparing the same
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
CN1283215C (zh) 2000-06-28 2006-11-08 A·J·舒克拉 生物活性物质的可生物降解载体和释放系统
US7396841B2 (en) 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
RO120121B1 (ro) 2000-12-18 2005-09-30 Elena Ionaşcu Soluţie injectabilă, cu efect antiinflamator, procedeu de obţinere şi metodă de tratament a bolilor autoimune
WO2002070399A1 (en) 2001-03-06 2002-09-12 Texas Research International, Inc. A chemically and biologically resistant hydration system
US6676958B2 (en) 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
KR100954741B1 (ko) 2001-06-29 2010-04-27 메드 그래프트 마이크로텍 인코포레이션 생분해성 주사가능한 이식제 및 관련된 제조방법과 용도
EP1413310A1 (en) 2001-07-09 2004-04-28 Yamanouchi Pharmaceutical Co. Ltd. Sustained-release compositions for injection and process for producing the same
US6733813B2 (en) 2001-08-02 2004-05-11 Ocean Spray Cranberries, Inc. Process for producing acids-enriched juice and acids-reduced juice
JP5078217B2 (ja) 2001-11-14 2012-11-21 デュレクト コーポレーション 注入可能なデポー組成物およびそれらの使用
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2003051398A1 (en) 2001-12-18 2003-06-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenteral composition of paracetamol
CN1171610C (zh) 2002-04-23 2004-10-20 张瑞香 一种治疗心脑血管和眼底病的中药针剂及其制备方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
EP1554304B1 (en) 2002-10-17 2009-06-10 The University Of British Columbia Ship 1 modulators
CN1329029C (zh) 2002-10-25 2007-08-01 冬姆佩制药股份公司 含有2－芳基丙酸盐的无痛可注射组合物
EA011708B1 (ru) 2002-12-18 2009-04-28 Алгоркс Фармасьютикалз, Инк. Применение транс- капсаицина
CN1507858A (zh) 2002-12-19 2004-06-30 王玉万 含氟化氯霉素的兽用液体制剂
DK2526996T3 (da) 2002-12-20 2019-12-02 Xeris Pharmaceuticals Inc Formulering til intrakutan injektion
AU2003230899A1 (en) 2003-04-14 2004-11-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
EP1468697B1 (en) 2003-04-14 2007-12-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
KR100517643B1 (ko) 2003-07-25 2005-09-28 한국과학기술연구원 온도 감응성 폴리포스파젠계 고분자, 이의 제조방법 및이를 이용한 주입형 온도 감응성 폴리포스파젠 하이드로젤
DE60305687T2 (de) 2003-07-31 2007-02-22 Emdoka Bvba, Drug Registration And Marketing Wässrige injizierbare Suspensionen für Tiere enthaltend Florfenicol
US20050100538A1 (en) 2003-07-31 2005-05-12 Attawia Mohamed Intradiscal injection of anti-oxidants
WO2004057939A2 (en) 2003-08-22 2004-07-15 Unaxis Balzers Aktiengesellschaft Method for the bonding of disk-shaped substrates and apparatus for carrying out the method
CN1856296A (zh) 2003-09-30 2006-11-01 阿库斯菲尔公司 可注射的、口服、或局部用缓释药物制剂
EP1722819B1 (en) 2004-03-12 2007-12-26 Intercell AG Method for solubilising peptide mixtures
US20050240166A1 (en) 2004-04-26 2005-10-27 Microsolutions, Inc. Implantable device, formulation and method for anti-psychotic therapy using risperidone
CA2566075A1 (en) 2004-05-12 2005-12-01 Baxter Healthcare S.A. Microspheres comprising protein and showing injectability at high concentrations of said agent
US20060160823A1 (en) 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
WO2006032026A2 (en) 2004-09-13 2006-03-23 Pr Pharmaceuticals, Inc. Long acting injectable crystal formulations of estradiol metabolites and methods of using same
WO2006081364A2 (en) 2005-01-27 2006-08-03 Erimos Pharmaceuticals Llc Formulations for injection of catecholic butanes, including ndga compounds, into animals
AU2006235183B2 (en) * 2005-04-08 2011-02-10 Amylin Pharmaceuticals, Llc Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent
US20080305161A1 (en) 2005-04-13 2008-12-11 Pfizer Inc Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
EP1891067B1 (en) 2005-06-17 2016-01-13 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
JP5242415B2 (ja) 2006-01-18 2013-07-24 フォアシーエイサー ファーマシューティカルズ インコーポレイテッド 高い安定性を持つ薬理組成物
AR054215A1 (es) 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
WO2007132732A1 (ja) 2006-05-17 2007-11-22 Terumo Kabushiki Kaisha 留置針組立体
WO2007140312A2 (en) 2006-05-25 2007-12-06 The General Hospital Corporation Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
NZ575435A (en) 2006-09-07 2012-01-12 Merial Ltd Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
AR063120A1 (es) 2006-10-05 2008-12-30 Panacea Biotec Ltd Composiciones inyectables de deposito y proceso para prepararlas
WO2008098212A2 (en) 2007-02-08 2008-08-14 Diobex, Inc. Extended release formulations of glucagon and other peptides and proteins
WO2008124522A2 (en) 2007-04-04 2008-10-16 Biodel, Inc. Amylin formulations
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
US20100120660A1 (en) 2007-04-30 2010-05-13 Per Balschmidt Highly concentrated insulin solutions and compositions
EP2152245B1 (en) 2007-04-30 2015-12-02 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
JP5539875B2 (ja) 2007-08-31 2014-07-02 アルキメデス・デベロップメント・リミテッド 非水性医薬組成物
US20090088393A1 (en) 2007-09-28 2009-04-02 Zomanex, Llc Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
WO2009060473A2 (en) 2007-11-06 2009-05-14 Panacea Biotec Limited Injectable compositions, processes and uses thereof
EP2060268A1 (en) 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
CA2702437C (en) 2007-11-28 2013-06-25 Teva Pharmaceutical Industries Ltd. Method of delaying the onset of clinically definite multiple sclerosis
CA2709677C (en) 2007-12-21 2017-03-14 Lin Zhi Selective androgen receptor modulators (sarms) and uses thereof
NZ601913A (en) 2008-01-15 2014-02-28 Abbott Gmbh & Co Kg Powdered protein compositions and methods of making same
KR101517415B1 (ko) 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
KR20110036075A (ko) 2008-07-23 2011-04-06 바라트 쎄럼스 앤드 백신스 리미티드 안정한 주입 가능 수중유형 도세타셀 나노에멀젼
GB0815435D0 (en) * 2008-08-22 2008-10-01 Camurus Ab Formulations
CA2735146A1 (en) 2008-08-25 2010-03-04 Denki Kagaku Kogyo Kabushiki Kaisha Syringe
JP5670335B2 (ja) 2008-09-25 2015-02-18 セファロン、インク． ベンダムスチン液体製剤
US20110118578A1 (en) 2009-11-17 2011-05-19 Roche Diagnostics Operations, Inc. Hypoglycemic treatment methods and systems
US20110223208A1 (en) 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
JP5632226B2 (ja) 2010-07-30 2014-11-26 株式会社細川洋行 医療用多層チューブ、および医療用輸液バッグ
MX342675B (es) * 2011-03-10 2016-10-07 Xeris Pharmaceuticals Inc Formulaciones estables para inyeccion parenteral de farmacos de peptido.
PL2773331T3 (pl) 2011-10-31 2016-08-31 Xeris Pharmaceuticals Inc Preparaty do leczenia cukrzycy
CN104427974B (zh) 2012-05-18 2018-03-23 基因泰克公司 高浓度单克隆抗体配制剂
US9522235B2 (en) 2012-05-22 2016-12-20 Kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
JP2015526523A (ja) 2012-08-29 2015-09-10 マンカインド コーポレイション 高血糖症の治療のための方法および組成物
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
JP6763777B2 (ja) 2014-02-06 2020-09-30 ゼリス ファーマシューティカルズ インコーポレイテッド 安定なペプチド製剤、および調製のための方法
WO2015153728A1 (en) 2014-04-02 2015-10-08 Xeris Pharmaceuticals, Inc. Polar aprotic solvent-compatible infusion sets, components, and methods

Similar Documents

Publication Publication Date Title
JP2018528242A5 (cg-RX-API-DMAC7.html)
JP6835831B2 (ja) 非プロトン性極性溶媒中の安定な治療用グルカゴン製剤を製造するための方法
JP2014507484A5 (cg-RX-API-DMAC7.html)
JP2017519018A5 (cg-RX-API-DMAC7.html)
BR112013023062B1 (pt) Solução estável para a injeção parenteral e método de fabricação da mesma
BRPI0616300A2 (pt) formulaÇço aquosa de hfsh
JP2017514868A5 (cg-RX-API-DMAC7.html)
JP2016503058A5 (cg-RX-API-DMAC7.html)
JP2017516848A5 (cg-RX-API-DMAC7.html)
JP2017514924A5 (cg-RX-API-DMAC7.html)
WO2015190378A1 (ja) 安定なアダリムマブ水性製剤
CN110876259A (zh) 注射用组合物
ES3002132T3 (en) Lyophilized pharmaceutical composition of fc-peptide fusion protein
HRP20201696T1 (hr) Farmaceutska parenteralna formulacija koja sadrži kargluminsku kiselinu
UY37550A (es) Nueva formulación que comprende un derivado de bencimidazol
JP2016507535A5 (cg-RX-API-DMAC7.html)
US12115164B2 (en) Pemetrexed formulations
JP2010105965A (ja) バンコマイシン製剤
TW202304426A (zh) 用於注射之包含１－（５－（２，４－二氟苯基）－１－（（３－氟苯基）磺醯基）－４－甲氧基－１ｈ－吡咯－３－基）－ｎ－甲基甲胺的新調配物
JPWO2017179683A1 (ja) ミカファンギンの安定化された医薬組成物
CN111787919B (zh) 保存稳定性优异的医药组合物
RU2829138C2 (ru) Новый состав для инъекций, включающий 1-(5-(2,4-дифторфенил)-1-((3-фторфенил)сульфонил)-4-метокси-1h-пиррол-3-ил)-n-метилметанамин
JPWO2019147718A5 (cg-RX-API-DMAC7.html)
WO2015056613A1 (ja) 安定化されたポリペプチド水性製剤
TW201831184A (zh) 含有普多沙星(pradofloxacin)之液態組成物